Equity Compensation and Other Benefit Plans (Tables)

3 Months Ended

Mar. 31, 2023

Compensation Related Costs [Abstract]

Schedule of expenses related to equity-based compensation

The following table presents the Company’s expenses related to its equity-based compensation instruments for the three months ended March 31, 2023 and 2022:

	Three Months Ended March 31,
(In Thousands)	2023		2022
RSUs	$	3,020	$	2,645
Total	$	3,020	$	2,645

Schedule of expenses related to deferred compensation plans

The following table presents the Company’s expenses related to its Deferred Plans for the three months ended March 31, 2023 and 2022:

	Three Months Ended March 31,
(In Thousands)	2023		2022
Non-employee directors	$	109	$	(278)
Total	$	109	$	(278)

Schedule of aggregate income deferred by participants and associated liability under deferred compensation plans

The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through March 31, 2023 and December 31, 2022 that had not been distributed and the Company’s associated liability for such deferrals at March 31, 2023 and December 31, 2022:

	March 31, 2023				December 31, 2022
(In Thousands)	Undistributed Income Deferred (1)		Liability Under Deferred Plans		Undistributed Income Deferred (1)		Liability Under Deferred Plans
Non-employee directors	$	2,431	$	1,748	$	2,923	$	1,953
Total	$	2,431	$	1,748	$	2,923	$	1,953

(1)  Represents the cumulative amounts that were deferred by participants through March 31, 2023 and December 31, 2022, which had not been distributed through such respective date.